Skip to content
Agree.net – Lifestyle
Author:
ZENTALIS PHARMACEUTICALS
Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering
August 13, 2026
Zentalis Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Updates
August 6, 2026
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 3, 2026
Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026
July 17, 2026
Suffolk County DWI Defense Attorney Jason Bassett Details CDL Disqualification Risks and Defense Options for Commercial Drivers Facing DWI Charges
July 7, 2026
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 1, 2026
Zentalis Strengthens Commercial Leadership with Appointments of Shannon Campbell to Board of Directors and Sarah Kelly as SVP of Commercial Strategy
May 27, 2026
Zentalis Pharmaceuticals to Present Phase 1b MUIR Trial Data Showing Encouraging Clinical Activity and Manageable Safety Profile of Azenosertib Plus Paclitaxel in Platinum-Resistant Ovarian Cancer at ASCO 2026
May 21, 2026
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
May 13, 2026
Zentalis Pharmaceuticals Reports First Quarter 2026 Financial Results and Clinical Progress
May 12, 2026
1
2
Next Page
→